|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
ES2205132T5
(es)
*
|
1996-10-01 |
2012-06-18 |
Geron Corporation |
Subunidad catalítica de la telomerasa humana
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US6251665B1
(en)
*
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
AU3456099A
(en)
|
1998-03-31 |
1999-10-18 |
Geron Corporation |
Methods and compositions for eliciting an immune response to a telomerase antigen
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
*
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
US20020192681A1
(en)
*
|
2000-10-24 |
2002-12-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
US20030059834A1
(en)
*
|
2001-02-01 |
2003-03-27 |
Chang Nancy T. |
Methods to generate and identify monoclonal antibodies to a large number of human antigens
|
|
DE10112851C1
(de)
*
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
WO2002087627A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated t cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
ES2240745T3
(es)
|
2001-06-05 |
2005-10-16 |
Curevac Gmbh |
Composicion farmaceutica que contiene un arnm estabilizado y optimizado para la traduccion, adecuada como vacuna y como regenerante de tejidos.
|
|
EP1432791B2
(en)
*
|
2001-09-06 |
2013-10-23 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
JP2005526001A
(ja)
*
|
2001-10-04 |
2005-09-02 |
アグイラルーコルドバ，カリオス，エスツアルド |
遺伝子療法用キメラ型ウイルスベクター
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
AU2003253790A1
(en)
*
|
2002-07-05 |
2004-01-23 |
Duke University |
Angio-immunotherapy
|
|
WO2004016803A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
EP2267021B1
(en)
|
2002-09-12 |
2015-02-18 |
Oncotherapy Science, Inc. |
KDR peptides and vaccines comprising the same
|
|
WO2004053095A2
(en)
*
|
2002-12-10 |
2004-06-24 |
Merix Bioscience, Inc. |
In situ maturation of dendritic cells
|
|
ES2890023T3
(es)
*
|
2002-12-13 |
2022-01-17 |
Alphavax Inc |
Partículas alfavíricas y métodos de preparación
|
|
CA2509973C
(en)
*
|
2002-12-13 |
2013-02-26 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
ES2543084T3
(es)
*
|
2003-02-18 |
2015-08-14 |
Baylor College Of Medicine |
Activación inducida en células dendríticas
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
JP2006518219A
(ja)
*
|
2003-02-18 |
2006-08-10 |
マックスサイト インコーポレーティッド |
電気穿孔法による細胞への抗原の負荷方法
|
|
JP5016305B2
(ja)
*
|
2003-03-20 |
2012-09-05 |
アルファヴァックス，インコーポレイテッド |
改良されたアルファウイルスレプリコンおよびヘルパー構築物
|
|
AU2004257214B2
(en)
*
|
2003-07-11 |
2010-04-22 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
CN1882603A
(zh)
*
|
2003-11-25 |
2006-12-20 |
阿哥斯医疗公司 |
mRNA转染的抗原呈递细胞
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
EP1730263A4
(en)
*
|
2004-03-02 |
2008-01-23 |
Tsuneya Ohno |
METHODS AND COMPOSITIONS RELATING TO HYBRID CELL VACCINES FOR TREATMENT AND CANCER PREVENTION
|
|
ATE420965T1
(de)
*
|
2004-05-18 |
2009-01-15 |
Alphavax Inc |
Von tc-83 abgeleitete alphavirus-vektoren, partikel und verfahren
|
|
WO2005116261A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Albert Einstein College Of Medecine Of Yeshiva University |
Rna expression microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
PL1794327T3
(pl)
*
|
2004-09-14 |
2017-04-28 |
Argos Therapeutics, Inc. |
Niezależna od szczepu amplifikacja patogenów i szczepionki przeciwko nim
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
ES2459466T3
(es)
|
2005-02-25 |
2014-05-09 |
Oncotherapy Science, Inc. |
Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
|
|
PT2095822E
(pt)
|
2005-02-28 |
2013-12-09 |
Oncotherapy Science Inc |
Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos
|
|
KR20170086700A
(ko)
|
2005-04-08 |
2017-07-26 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
|
KR20130087639A
(ko)
|
2005-07-27 |
2013-08-06 |
온코세라피 사이언스 가부시키가이샤 |
대장암 관련 유전자 ｔｏｍ３４
|
|
ES2542141T3
(es)
|
2005-10-17 |
2015-07-31 |
Sloan Kettering Institute For Cancer Research |
Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
|
|
CA2645766A1
(en)
|
2006-04-10 |
2007-10-25 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US20070281336A1
(en)
|
2006-04-14 |
2007-12-06 |
Epicentre Technologies |
Kits and methods for generating 5' capped RNA
|
|
CA2658000C
(en)
|
2006-08-18 |
2017-02-07 |
Argos Therapeutics, Inc. |
Use of cd83 in combination therapies
|
|
CN102850433B
(zh)
|
2006-10-17 |
2016-03-02 |
肿瘤疗法科学股份有限公司 |
用于表达mphosph1或depdc1多肽的癌症的肽疫苗
|
|
US8691210B2
(en)
*
|
2006-10-19 |
2014-04-08 |
David M Spencer |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI494319B
(zh)
|
2007-02-21 |
2015-08-01 |
Oncotherapy Science Inc |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TWI434853B
(zh)
|
2007-04-11 |
2014-04-21 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
AU2008266807B2
(en)
|
2007-06-21 |
2012-08-16 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
CA2696597C
(en)
|
2007-08-20 |
2017-05-16 |
Oncotherapy Science, Inc. |
Foxm1 peptide and medicinal agent comprising the same
|
|
EP2254998B1
(en)
|
2008-02-28 |
2015-12-23 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
WO2009155535A2
(en)
|
2008-06-20 |
2009-12-23 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
JP6133538B2
(ja)
|
2008-09-22 |
2017-05-24 |
ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ |
Ｃｄ４０およびパターン認識受容体アダプターを誘発することによる免疫応答を生成するための方法および組成物
|
|
US8697854B2
(en)
|
2008-11-24 |
2014-04-15 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
High affinity T cell receptor and use thereof
|
|
TWI539160B
(zh)
|
2008-12-05 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US9841426B2
(en)
*
|
2009-03-11 |
2017-12-12 |
Marker Gene Technologies, Inc |
Intracellular organelle peptide targeted enzyme substrates
|
|
EP2408913B1
(en)
|
2009-03-18 |
2016-12-14 |
Oncotherapy Science, Inc. |
Neil3 peptides and vaccines including the same
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
BR112012022641A2
(pt)
|
2010-03-11 |
2017-02-14 |
Oncotherapy Science Inc |
peptídeos hjurp e vacinas que incluem os mesmos
|
|
TWI538685B
(zh)
|
2010-04-02 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
SMT202200321T1
(it)
|
2010-10-01 |
2022-09-14 |
Modernatx Inc |
Acidi ribonucleici contenenti n1-metil-pseudouracili e loro usi
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
US9458447B2
(en)
|
2011-08-12 |
2016-10-04 |
Oncotherapy Science, Inc. |
MPHOSPH1 peptides and vaccines including the same
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
PH12014500720A1
(en)
|
2011-10-28 |
2014-06-30 |
Oncotherapy Science Inc |
Topk peptides and vaccines including the same
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
AU2013207669C1
(en)
|
2012-01-13 |
2018-05-31 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
JP2015513913A
(ja)
|
2012-04-02 |
2015-05-18 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ポリヌクレオチド
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP2872530A4
(en)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
WO2014113490A2
(en)
|
2013-01-15 |
2014-07-24 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
HK1217000A1
(zh)
|
2013-03-14 |
2016-12-16 |
Bellicum Pharmaceuticals, Inc. |
控制t细胞增殖的方法
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
ES2791598T3
(es)
|
2013-06-05 |
2020-11-05 |
Bellicum Pharmaceuticals Inc |
Métodos para inducir apoptosis parcial utilizando polipéptidos de caspasa
|
|
WO2015047901A1
(en)
|
2013-09-24 |
2015-04-02 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
MX2016004249A
(es)
|
2013-10-03 |
2016-11-08 |
Moderna Therapeutics Inc |
Polinulcleotidos que codifican el receptor de lipoproteina de baja densidad.
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
JP6772063B2
(ja)
|
2014-02-14 |
2020-10-21 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
誘導可能なキメラポリペプチドを使用して細胞を活性化するための方法
|
|
US12214038B2
(en)
*
|
2014-07-22 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
CA2956265C
(en)
|
2014-08-04 |
2023-03-21 |
Oncotherapy Science, Inc. |
Urlc10-derived peptide and vaccine containing same
|
|
SG11201700839SA
(en)
|
2014-08-04 |
2017-03-30 |
Oncotherapy Science Inc |
Cdca1-derived peptide and vaccine containing same
|
|
EP4353321A3
(en)
|
2014-08-04 |
2024-07-10 |
OncoTherapy Science, Inc. |
Koc1-derived peptide and vaccine including same
|
|
CA2959168A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
CA2961749C
(en)
*
|
2014-09-17 |
2021-01-12 |
The Johns Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
|
|
CN107106611B
(zh)
*
|
2014-10-27 |
2021-11-23 |
弗雷德哈钦森癌症研究中心 |
用于提高过继细胞免疫疗法效力的组合物和方法
|
|
WO2016071758A1
(en)
|
2014-11-03 |
2016-05-12 |
Leiden University Medical Center |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
EP3360886B1
(en)
|
2015-10-08 |
2023-01-25 |
Oncotherapy Science, Inc. |
Foxm1-derived peptide, and vaccine including same
|
|
US11780934B2
(en)
|
2016-02-05 |
2023-10-10 |
Institut Pasteur |
Use of inhibitors of ADAM12 as adjuvants in tumor therapies
|
|
EP3452082A1
(en)
|
2016-05-04 |
2019-03-13 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
EP3478073B1
(en)
*
|
2016-06-29 |
2025-11-26 |
Duke University |
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
|
|
CN111818940A
(zh)
*
|
2018-01-05 |
2020-10-23 |
安德烈亚斯·罗尔夫-乔纳斯·尼尔森 |
用作疫苗的内源性肿瘤衍生的环状rna及其蛋白质
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
US20250144143A1
(en)
*
|
2023-11-06 |
2025-05-08 |
Immunitybio, Inc. |
Virally Educated T cells
|